- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Fluticasone furoate/umeclidinium bromide/vilanterol trifenatate
Total 60 results
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited States, Germany, Japan, Ukraine, Estonia, Belgium, France, Sweden, Netherlands, Philippines, Denmark, Hungary, Norway, Slovakia
-
Chiesi Farmaceutici S.p.A.CompletedChronic Obstructive Pulmonary Disease | AsthmaUnited Kingdom
-
Brigham and Women's HospitalCompleted
-
GlaxoSmithKlineRecruitingAsthmaUnited States, Canada, Argentina, Australia, Japan, Korea, Republic of, Taiwan
-
Samsung Medical CenterRecruitingChronic Obstructive Pulmonary Disease | Non Small Cell Lung CancerKorea, Republic of
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructivePuerto Rico, United States, Australia, Argentina, France, Germany, Japan, Netherlands, Russian Federation, Spain, Ukraine, Finland, Czechia, Poland, Belgium, Chile, Peru, South Africa, Sweden, Thailand, Israel, Korea, Republic of, C... and more
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited States, Russian Federation, Ukraine, Germany, Peru, Poland, France, Romania, Italy, Mexico
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary DiseaseUnited States
-
National Institute of Respiratory Diseases, MexicoCompleted
-
GlaxoSmithKlineCompletedAsthmaUnited States, Argentina, Germany, Romania, Russian Federation, Ukraine, Chile, Sweden, Mexico, Netherlands, Poland
-
GlaxoSmithKlineCompletedAsthmaKorea, Republic of, China, Philippines
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited States, Argentina, Japan, Poland, Romania, Russian Federation, Spain, Ukraine, Germany, Taiwan, Bulgaria, Hungary, France, Philippines, South Africa, Thailand, Israel, Korea, Republic of, Australia, Mexico, Slovakia, United... and more
-
GlaxoSmithKlineWithdrawnPulmonary Disease, Chronic ObstructiveCanada, Germany
-
Bispebjerg HospitalRigshospitalet, DenmarkCompletedPharmacokineticsDenmark
-
Morten Hostrup, PhDRecruiting
-
GlaxoSmithKlineCompleted
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited States, Canada, Germany, Romania, Poland, Czechia
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveUnited States
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited States, Germany, Japan, Poland, Romania, Russian Federation, Ukraine, Taiwan, Bulgaria, South Africa, Korea, Republic of
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveUnited States
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited States, Germany, Spain, Netherlands, Canada
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited States, Germany, Philippines, Thailand, Korea, Republic of, Norway
-
GlaxoSmithKlineCompletedAsthmaUnited States
-
GlaxoSmithKlineCompleted
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveArgentina, Australia, United States, Germany, Chile, Korea, Republic of, Mexico, Canada, South Africa, Romania
-
Morten Hostrup, PhDRecruitingExercise PerformanceDenmark
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited States, Germany, Canada, Korea, Republic of
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited States, Korea, Republic of, Chile, Poland, Czech Republic
-
GlaxoSmithKlineCompleted
-
University of SaskatchewanCompleted
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveGermany, Russian Federation, Spain, Netherlands, Hungary, Denmark, Poland, Czechia
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveUnited States
-
GlaxoSmithKlineCompletedAsthmaUnited States, Germany, Japan, Romania, Ukraine, Poland
-
GlaxoSmithKlineCompletedAsthmaUnited States, Germany, Japan, Romania, Russian Federation, Poland
-
GlaxoSmithKlineWithdrawn
-
University of VirginiaRecruitingChronic Obstructive Pulmonary DiseaseUnited States
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveTaiwan, China, Philippines, Korea, Republic of
-
GlaxoSmithKlineCompleted
-
GlaxoSmithKlineWithdrawnLegend: TRELEGY Real World Chronic Obstructive Pulmonary Disease (COPD) Effectiveness Study (LEGEND)Pulmonary Disease, Chronic ObstructiveUnited States
-
GlaxoSmithKlineParexelWithdrawn
-
GlaxoSmithKlineCompletedAsthmaUnited Kingdom, Germany, New Zealand
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveArgentina, France, Germany, Russian Federation, Ukraine, Italy, Norway
-
University of DundeeBoehringer Ingelheim; NHS TaysideCompletedChronic Obstructive Pulmonary DiseaseUnited Kingdom
-
GlaxoSmithKlineCompleted
-
GlaxoSmithKlineCompleted
-
GlaxoSmithKlineCompleted
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveFrance, Germany, Spain, Russian Federation, Belgium, Ukraine, Philippines, Italy, Poland
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited States, Germany, Romania, Russian Federation, Spain, Bulgaria, Canada, Hungary, Argentina